+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Synthetic Biology Market Research Report by Tool (Chassis Organisms, Cloning Technology Kits, and Enzymes), Technology, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 137 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5533147
UP TO OFF until Dec 31st 2022
The United States Synthetic Biology Market size was estimated at USD 3,625.00 million in 2021, USD 3,968.91 million in 2022, and is projected to grow at a CAGR 11.50% to reach USD 6,968.69 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Synthetic Biology to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Tool, the market was studied across Chassis Organisms, Cloning Technology Kits, Enzymes, Oligonucleotides & Synthetic DNA, Synthetic Cells, and Xeno-nucleic Acids.
  • Based on Technology, the market was studied across Bioinformatics, Cloning, Gene Synthesis, Genome Engineering, Measurement & Modeling, Microfluidics, Nanotechnology, Sequencing, and Site-directed Mutagenesis.
  • Based on Application, the market was studied across Environmental Applications, Food & Agriculture, Industrial Applications, and Medical Applications. The Environmental Applications is further studied across Bioremediation and Biosensing. The Industrial Applications is further studied across Biofuel And Renewable Energy, Biomaterials & Green Chemicals, and Industrial Enzymes. The Industrial Enzymes is further studied across Paper Industry and Textile Industry. The Medical Applications is further studied across Artificial Tissue & Tissue Regeneration, Drug Discovery And Therapeutics, and Pharmaceuticals. The Artificial Tissue & Tissue Regeneration is further studied across Bio-synthesis and Stem Cell Regulation. The Drug Discovery And Therapeutics is further studied across Cancer Detection & Diagnostics and Drug Discovery And Therapeutic Applications.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Synthetic Biology market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Synthetic Biology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Synthetic Biology Market, including Agilent Technologies, Inc., Amyris, Inc., Arzeda, Atum, Business Overview, Codexis, Inc., Creative Enzymes, Cyrus Biotechnology, Inc., Eurofins Scientific, Genscript Biotech Corporation, Ginkgo Bioworks, Integrated Dna Technologies, Inc., Intrexon Corporation, Merck Kgaa, New England Biolabs, Novozymes A/S, Synthego Corporation, Synthetic Genomics, Inc. (SGI), Teselagen, Thermo Fisher Scientific, Inc., and Twist Bioscience.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Synthetic Biology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Synthetic Biology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Synthetic Biology Market?
4. What is the competitive strategic window for opportunities in the United States Synthetic Biology Market?
5. What are the technology trends and regulatory frameworks in the United States Synthetic Biology Market?
6. What is the market share of the leading vendors in the United States Synthetic Biology Market?
7. What modes and strategic moves are considered suitable for entering the United States Synthetic Biology Market?
Frequently Asked Questions about the U.S. Synthetic Biology Market

What is the estimated value of the U.S. Synthetic Biology Market?

The U.S. Synthetic Biology Market was estimated to be valued at $3625 Million in 2021.

What is the growth rate of the U.S. Synthetic Biology Market?

The growth rate of the U.S. Synthetic Biology Market is 11.5%, with an estimated value of $6968.69 Million by 2027.

What is the forecasted size of the U.S. Synthetic Biology Market?

The U.S. Synthetic Biology Market is estimated to be worth $6968.69 Million by 2027.

Who are the key companies in the U.S. Synthetic Biology Market?

Key companies in the U.S. Synthetic Biology Market include Agilent Technologies, Inc., Amyris, Inc., Arzeda, Atum, Business Overview, Codexis, Inc., Creative Enzymes, Cyrus Biotechnology, Inc. and Genscript Biotech Corporation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Synthetic Biology Market, by Tool
6.1. Introduction
6.2. Chassis Organisms
6.3. Cloning Technology Kits
6.4. Enzymes
6.5. Oligonucleotides & Synthetic DNA
6.6. Synthetic Cells
6.7. Xeno-nucleic Acids
7. Synthetic Biology Market, by Technology
7.1. Introduction
7.2. Bioinformatics
7.3. Cloning
7.4. Gene Synthesis
7.5. Genome Engineering
7.6. Measurement & Modeling
7.7. Microfluidics
7.8. Nanotechnology
7.9. Sequencing
7.10. Site-directed Mutagenesis
8. Synthetic Biology Market, by Application
8.1. Introduction
8.2. Environmental Applications
8.2.1. Bioremediation
8.2.2. Biosensing
8.3. Food & Agriculture
8.4. Industrial Applications
8.4.1. Biofuel And Renewable Energy
8.4.2. Biomaterials & Green Chemicals
8.4.3. Industrial Enzymes
8.4.3.1. Paper Industry
8.4.3.2. Textile Industry
8.5. Medical Applications
8.5.1. Artificial Tissue & Tissue Regeneration
8.5.1.1. Bio-synthesis
8.5.1.2. Stem Cell Regulation
8.5.2. Drug Discovery And Therapeutics
8.5.2.1. Cancer Detection & Diagnostics
8.5.2.2. Drug Discovery And Therapeutic Applications
8.5.3. Pharmaceuticals
9. California Synthetic Biology Market10. Florida Synthetic Biology Market11. Illinois Synthetic Biology Market12. New York Synthetic Biology Market13. Ohio Synthetic Biology Market14. Pennsylvania Synthetic Biology Market15. Texas Synthetic Biology Market
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Agilent Technologies, Inc.
17.2. Amyris, Inc.
17.3. Arzeda
17.4. Atum
17.5. Business Overview
17.6. Codexis, Inc.
17.7. Creative Enzymes
17.8. Cyrus Biotechnology, Inc.
17.9. Eurofins Scientific
17.10. Genscript Biotech Corporation
17.11. Ginkgo Bioworks
17.12. Integrated Dna Technologies, Inc.
17.13. Intrexon Corporation
17.14. Merck Kgaa
17.15. New England Biolabs
17.16. Novozymes A/S
17.17. Synthego Corporation
17.18. Synthetic Genomics, Inc. (SGI)
17.19. Teselagen
17.20. Thermo Fisher Scientific, Inc.
17.21. Twist Bioscience
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES SYNTHETIC BIOLOGY MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES SYNTHETIC BIOLOGY MARKET DYNAMICS
FIGURE 8. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOL, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOL, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOL, 2027
FIGURE 11. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY CHASSIS ORGANISMS, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY CHASSIS ORGANISMS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY CLONING TECHNOLOGY KITS, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY CLONING TECHNOLOGY KITS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY OLIGONUCLEOTIDES & SYNTHETIC DNA, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY OLIGONUCLEOTIDES & SYNTHETIC DNA, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC CELLS, 2019-2027 (USD MILLION)
FIGURE 20. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC CELLS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY XENO-NUCLEIC ACIDS, 2019-2027 (USD MILLION)
FIGURE 22. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY XENO-NUCLEIC ACIDS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 24. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 25. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 26. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOINFORMATICS, 2019-2027 (USD MILLION)
FIGURE 27. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOINFORMATICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY CLONING, 2019-2027 (USD MILLION)
FIGURE 29. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY CLONING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 30. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY GENE SYNTHESIS, 2019-2027 (USD MILLION)
FIGURE 31. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY GENE SYNTHESIS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 32. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME ENGINEERING, 2019-2027 (USD MILLION)
FIGURE 33. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME ENGINEERING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 34. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY MEASUREMENT & MODELING, 2019-2027 (USD MILLION)
FIGURE 35. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY MEASUREMENT & MODELING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 36. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY MICROFLUIDICS, 2019-2027 (USD MILLION)
FIGURE 37. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY MICROFLUIDICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 38. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY NANOTECHNOLOGY, 2019-2027 (USD MILLION)
FIGURE 39. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY NANOTECHNOLOGY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 40. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY SEQUENCING, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY SEQUENCING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 42. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY SITE-DIRECTED MUTAGENESIS, 2019-2027 (USD MILLION)
FIGURE 43. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY SITE-DIRECTED MUTAGENESIS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 44. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 45. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2027
FIGURE 47. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, 2019-2027 (USD MILLION)
FIGURE 48. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 49. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOREMEDIATION, 2019-2027 (USD MILLION)
FIGURE 50. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOREMEDIATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 51. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOSENSING, 2019-2027 (USD MILLION)
FIGURE 52. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOSENSING, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 53. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, 2019-2027 (USD MILLION)
FIGURE 54. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 55. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL APPLICATIONS, 2019-2027 (USD MILLION)
FIGURE 56. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL APPLICATIONS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 57. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUEL AND RENEWABLE ENERGY, 2019-2027 (USD MILLION)
FIGURE 58. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUEL AND RENEWABLE ENERGY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 59. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS & GREEN CHEMICALS, 2019-2027 (USD MILLION)
FIGURE 60. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS & GREEN CHEMICALS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 61. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, 2019-2027 (USD MILLION)
FIGURE 62. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 63. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY PAPER INDUSTRY, 2019-2027 (USD MILLION)
FIGURE 64. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY PAPER INDUSTRY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 65. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TEXTILE INDUSTRY, 2019-2027 (USD MILLION)
FIGURE 66. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TEXTILE INDUSTRY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 67. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY MEDICAL APPLICATIONS, 2019-2027 (USD MILLION)
FIGURE 68. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY MEDICAL APPLICATIONS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 69. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ARTIFICIAL TISSUE & TISSUE REGENERATION, 2019-2027 (USD MILLION)
FIGURE 70. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ARTIFICIAL TISSUE & TISSUE REGENERATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 71. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIO-SYNTHESIS, 2019-2027 (USD MILLION)
FIGURE 72. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIO-SYNTHESIS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 73. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STEM CELL REGULATION, 2019-2027 (USD MILLION)
FIGURE 74. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STEM CELL REGULATION, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 75. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY DRUG DISCOVERY AND THERAPEUTICS, 2019-2027 (USD MILLION)
FIGURE 76. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY DRUG DISCOVERY AND THERAPEUTICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 77. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY CANCER DETECTION & DIAGNOSTICS, 2019-2027 (USD MILLION)
FIGURE 78. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY CANCER DETECTION & DIAGNOSTICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 79. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, 2019-2027 (USD MILLION)
FIGURE 80. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 81. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY PHARMACEUTICALS, 2019-2027 (USD MILLION)
FIGURE 82. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 83. CALIFORNIA SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 84. FLORIDA SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 85. ILLINOIS SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 86. NEW YORK SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 87. OHIO SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 88. PENNSYLVANIA SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 89. TEXAS SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 90. UNITED STATES SYNTHETIC BIOLOGY MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 91. UNITED STATES SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 92. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES SYNTHETIC BIOLOGY MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES SYNTHETIC BIOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TOOL, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY CHASSIS ORGANISMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY CLONING TECHNOLOGY KITS, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENZYMES, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY OLIGONUCLEOTIDES & SYNTHETIC DNA, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY SYNTHETIC CELLS, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY XENO-NUCLEIC ACIDS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOINFORMATICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY CLONING, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY GENE SYNTHESIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY GENOME ENGINEERING, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY MEASUREMENT & MODELING, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY MICROFLUIDICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY NANOTECHNOLOGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY SEQUENCING, BY STATE, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY SITE-DIRECTED MUTAGENESIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOREMEDIATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOSENSING, BY STATE, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, BY STATE, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL APPLICATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOFUEL AND RENEWABLE ENERGY, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIOMATERIALS & GREEN CHEMICALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY INDUSTRIAL ENZYMES, BY STATE, 2019-2027 (USD MILLION)
TABLE 31. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY PAPER INDUSTRY, BY STATE, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY TEXTILE INDUSTRY, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY MEDICAL APPLICATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY ARTIFICIAL TISSUE & TISSUE REGENERATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY BIO-SYNTHESIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 36. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY STEM CELL REGULATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 37. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY DRUG DISCOVERY AND THERAPEUTICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY CANCER DETECTION & DIAGNOSTICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 40. UNITED STATES SYNTHETIC BIOLOGY MARKET SIZE, BY PHARMACEUTICALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 41. CALIFORNIA SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. CALIFORNIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOL, 2019-2027 (USD MILLION)
TABLE 43. CALIFORNIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 44. CALIFORNIA SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 45. FLORIDA SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. FLORIDA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOL, 2019-2027 (USD MILLION)
TABLE 47. FLORIDA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 48. FLORIDA SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 49. ILLINOIS SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. ILLINOIS SYNTHETIC BIOLOGY MARKET SIZE, BY TOOL, 2019-2027 (USD MILLION)
TABLE 51. ILLINOIS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 52. ILLINOIS SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 53. NEW YORK SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. NEW YORK SYNTHETIC BIOLOGY MARKET SIZE, BY TOOL, 2019-2027 (USD MILLION)
TABLE 55. NEW YORK SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 56. NEW YORK SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 57. OHIO SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. OHIO SYNTHETIC BIOLOGY MARKET SIZE, BY TOOL, 2019-2027 (USD MILLION)
TABLE 59. OHIO SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 60. OHIO SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 61. PENNSYLVANIA SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 62. PENNSYLVANIA SYNTHETIC BIOLOGY MARKET SIZE, BY TOOL, 2019-2027 (USD MILLION)
TABLE 63. PENNSYLVANIA SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 64. PENNSYLVANIA SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 65. TEXAS SYNTHETIC BIOLOGY MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. TEXAS SYNTHETIC BIOLOGY MARKET SIZE, BY TOOL, 2019-2027 (USD MILLION)
TABLE 67. TEXAS SYNTHETIC BIOLOGY MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 68. TEXAS SYNTHETIC BIOLOGY MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 69. UNITED STATES SYNTHETIC BIOLOGY MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 70. UNITED STATES SYNTHETIC BIOLOGY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 71. UNITED STATES SYNTHETIC BIOLOGY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 72. UNITED STATES SYNTHETIC BIOLOGY MARKET RANKING
TABLE 73. UNITED STATES SYNTHETIC BIOLOGY MARKET SHARE, BY KEY PLAYER, 2021
TABLE 74. UNITED STATES SYNTHETIC BIOLOGY MARKET MERGER & ACQUISITION
TABLE 75. UNITED STATES SYNTHETIC BIOLOGY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 76. UNITED STATES SYNTHETIC BIOLOGY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 77. UNITED STATES SYNTHETIC BIOLOGY MARKET INVESTMENT & FUNDING
TABLE 78. UNITED STATES SYNTHETIC BIOLOGY MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 79. UNITED STATES SYNTHETIC BIOLOGY MARKET: LICENSE & PRICING

Companies Mentioned

  • Agilent Technologies, Inc.
  • Amyris, Inc.
  • Arzeda
  • Atum
  • Business Overview
  • Codexis, Inc.
  • Creative Enzymes
  • Cyrus Biotechnology, Inc.
  • Eurofins Scientific
  • Genscript Biotech Corporation
  • Ginkgo Bioworks
  • Integrated Dna Technologies, Inc.
  • Intrexon Corporation
  • Merck Kgaa
  • New England Biolabs
  • Novozymes A/S
  • Synthego Corporation
  • Synthetic Genomics, Inc. (SGI)
  • Teselagen
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience

Methodology

Loading
LOADING...